Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M DeTora

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
International Journal of Clinical Practice|June 9, 2017
What is safety?: Miracles, benefit-risk assessments, and the "right to try"Lisa M DeTora
Current Medical Research and Opinion|May 31, 2022
Mapping author taxonomies and author criteria: good practices for thinking through complex authorship situationsLisa M DeTora
Clinical Therapeutics|September 19, 2019
Disclosures and Conflicts of Interest: Solving the Riddle, Wrapped in a Mystery, Inside an EnigmaLisa M DeTora, Leslie Citrome
Expert Review of Vaccines|April 13, 2006
An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccineMichael E Pichichero, Lisa M DeTora, David R Johnson
Infection and Drug Resistance|September 10, 2011
Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive diseaseMichael Bröker, Brian Cooper, Lisa M Detora, et al.
Current Medical Research and Opinion|April 16, 2019
Ghostwriting in biomedicine: a review of the published literatureLisa M DeTora, Michelle A Carey, Dikran Toroser, et al.
Medical Sciences (Basel, Switzerland)|March 6, 2021
Dental Care in Times of the COVID-19 Pandemic: A ReviewErfan Shamsoddin, Lisa M DeTora, Marcos Roberto Tovani-Palone, et al.
Expert Review of Vaccines|September 23, 2006
Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135Harry L Keyserling, Andrew J Pollard, Lisa M DeTora, et al.
Annals of Internal Medicine|March 20, 2023
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 UpdateLisa M DeTora, Trevor Lane, Angela Sykes, et al.
Current Medical Research and Opinion|February 16, 2024
Good Publication Practice (GPP) guidelines for company-sponsored biomedical research from the point of view of the diverse authors involved in its publicationLeslie Citrome, Lisa M DeTora, Dikran Toroser, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Clinical Practice|June 9, 2017
What is safety?: Miracles, benefit-risk assessments, and the "right to try"Lisa M DeTora
Current Medical Research and Opinion|May 31, 2022
Mapping author taxonomies and author criteria: good practices for thinking through complex authorship situationsLisa M DeTora
Clinical Therapeutics|September 19, 2019
Disclosures and Conflicts of Interest: Solving the Riddle, Wrapped in a Mystery, Inside an EnigmaLisa M DeTora, Leslie Citrome
Expert Review of Vaccines|April 13, 2006
An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccineMichael E Pichichero, Lisa M DeTora, David R Johnson
Infection and Drug Resistance|September 10, 2011
Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive diseaseMichael Bröker, Brian Cooper, Lisa M Detora, et al.
Current Medical Research and Opinion|April 16, 2019
Ghostwriting in biomedicine: a review of the published literatureLisa M DeTora, Michelle A Carey, Dikran Toroser, et al.
Medical Sciences (Basel, Switzerland)|March 6, 2021
Dental Care in Times of the COVID-19 Pandemic: A ReviewErfan Shamsoddin, Lisa M DeTora, Marcos Roberto Tovani-Palone, et al.
Expert Review of Vaccines|September 23, 2006
Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135Harry L Keyserling, Andrew J Pollard, Lisa M DeTora, et al.
Annals of Internal Medicine|March 20, 2023
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 UpdateLisa M DeTora, Trevor Lane, Angela Sykes, et al.
Current Medical Research and Opinion|February 16, 2024
Good Publication Practice (GPP) guidelines for company-sponsored biomedical research from the point of view of the diverse authors involved in its publicationLeslie Citrome, Lisa M DeTora, Dikran Toroser, et al.
Pageof 2